Abstract:Tissue macrophages play important roles in maintaining homeostasis in most organs of the body including the brain where microglia represent the resident phagocytic cells of this compartment. The possibility of one day harnessing macrophage plasticity to treat or ameliorate disorders including obesity, cancer, organ damage, intestinal disorders, neurodegeneration, and cardiovascular disease in which these cells play a role, is a very exciting prospect. Inflammatory signaling is required for regenerative repair, healing, and pathogen clearance functions. However, when the inflammatory response persists in a chronic fashion over an extended period of time, damage to neurons is followed by neuronal injury and dysfunction. Macrophages in the brain are heterogeneous arising from tissues during embryogenesis, and in the adult, from bone marrow derived monocytes that enter through the blood-brain-barrier. While much of our insight regarding macrophage functional subtypes has been garnered through elegant studies in mice, which are amenable to genetic manipulation, far less is known about such cells in human tissues, and particularly in the brain under normal, disease, or injurious conditions. In this regard, non-human primate models for human immunodeficiency virus have been extremely useful for understanding the contribution of bone marrow-derived monocytes in neurological disease and their interaction and impact on the activation state of resident microglia in the brain. This review will focus on what has been learned from the rhesus macaque models about the types of macrophages present in the brains of animals with encephalitis. In vitro studies, which have used human blood monocytes differentiated into macrophages to address the question of macrophage subsets in HIV infection will be highlighted. Recent insights on macrophage phenotype and persistent inflammation in the brain in HIV-associated neurocognitive disorder from immunohistochemical studies on human autopsy tissue will be examined.

Advances in understanding the immunity of the brain and its borders: Focus on brain macrophages

Border-associated macrophages in the central nervous system

Brain macrophage development, diversity and dysregulation in health and disease

WITHDRAWN: Border-associated macrophages in the central nervous system

Border‐Associated Macrophages: From Embryogenesis to Immune Regulation

Microglia and macrophages in glioblastoma: landscapes and treatment directions

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment

Brain perivascular macrophages: current understanding and future prospects

Brain border-associated macrophages: common denominators in infection, aging, and Alzheimer's disease?

Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection

Brain macrophage senescence in glioma

Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

CNS macrophages and peripheral myeloid cells in brain tumours

The niche matters: origin, function and fate of CNS-associated macrophages during health and disease

Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages

Brain-Engrafted Monocyte-derived Macrophages from Blood and Skull-Bone Marrow Exhibit Distinct Identities from Microglia

Macrophages/Microglia in the Glioblastoma Tumor Microenvironment

Macrophages: sentinels and regulators of the immune system

Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration